Amgen (NSDQ:AMGN) announced third-quarter earnings per share of $4.37, beating the consensus forecast of $3.80. Biosimilars growth and a strong base business drove growth in the quarter ending on Sept. 30. The company has been relatively steady in 2020, growing 11% in the first quarter and 6% in the second. “Our performance in the third quarter…